Hopefully we get that one.

The Oxford vaccine has been developed in a different way using methods that have been previously proven as safe apparently, it will also be much cheaper than the Moderna and Pfizer vaccines at 2.00 per vaccine rather than 30.00

Ross Lydall
Thu, 19 November 2020, 8:47 am GMT·8-min read
<p>Boost: The UK has ordered 100 million doses of the Oxford vaccine</p> (PA)
Boost: The UK has ordered 100 million doses of the Oxford vaccine

(PA)
The Covid vaccine being made by Oxford university is safe and works well in older adults most likely to become seriously ill or die from the virus, its creators revealed today.

In another major boost for hopes of bringing the pandemic to heel, they said the preliminary results for the UK’s main vaccine hope were “encouraging”.

The Government has ordered 100 million doses of the Oxford jab – the biggest proportion of the 355 million doses of a portfolio of vaccines it has bought.

The phase 2 results, which focus on safety and were published this morning in The Lancet medical journal, gave data on 560 healthy adults, including 240 over the age of 70.

The crucial phase 3 results, which will reveal the vaccine’s effectiveness in tens of thousands of volunteers across several countries including the UK, are due to be published in a few weeks.

The phase 3 results will also reveal how well the vaccine works in people with underlying health conditions – those most at risk from Covid.

Phase 3 results have already been published by rival vaccine makers Pfizer/BioNtech and Moderna, both of which showed around 95 per cent effectiveness.

Today’s results from the Oxford group, which is creating the vaccine with UK-based drugs firm AstraZeneca, showed the drug was better tolerated in older people but produced a similar immune response in both young and old trial participants.

The study compared the effect on people aged 56 and older with those aged 18-55. It found there were “few side effects” and that a T-cell immune response was sparked within 14 days of the first jab, both at low and standard doses.

This means the body’s immune system could find and attack cells infected with Covid.

A subsequent booster jab kick-started an antibody response within 28 days, enabling the virus to be attacked when circulating in the blood or lymphatic system.

The Oxford vaccine has a major advantage over the Pfizer/BioNTech drug in that it does not have to be stored at around -70C prior up to a few days before being administered.

The Oxford vaccine didnt have the headache and fatigue side effect that the others have

Its so strange that they are in a position to choose WHICH vaccine to have! Thats crazy. I didnt think there would be any sign of a vaccine until at least the end of next year!

Under normal circumstances there wouldn't be for several years, but the money funnelled into development (and, frankly the potential sales) of Covid vaccines has put the whole process into overdrive. Plus, of course, a shortened safety testing process. That's the downside.

the vaccines will sort themselves out by natural selection. Some will be better for old folks, some will be cheaper for struggling economies etc etc

Also posted on the TV thread.

I've lasted this long without catching corona so I wont be in a rush to get the jag.

The UK Oxford Vaccine is £2 a dose

Its consists of corona spikes and monkey flu virus..

No thank you!!!

How the Oxford COVID-19 vaccine works
The ChAdOx1 vaccine is a chimpanzee adenovirus vaccine vector. This is a harmless, weakened adenovirus that usually causes the common cold in chimpanzees. ChAdOx1 was chosen as the most suitable vaccine technology for a SARS-CoV-2 vaccine as it has been shown to generate a strong immune response from one dose in other vaccines. It has been genetically changed so that it is impossible for it to grow in humans. This also makes it safer to give to children, the elderly and anyone with a pre-existing condition such as diabetes. Chimpanzee adenoviral vectors are a very well-studied vaccine type, having been used safely in thousands of subjects.

Coronaviruses have club-shaped spikes on their outer coats, which form a corona – Latin for crown – on the virus surface. Immune responses from other coronavirus studies suggest that these spikes are a good target for a vaccine.


https://www.research.ox.ac.uk/Articl...vid-19-vaccine

What a ChAd.

The UK is expected to be the first country to to approve the vacinne and could get it as early as next week with NHS Staff and Over 65s the highest priority

I hope south london recieve the first doses..I've had a few cancellations lately for the first time since march..

Whoa whoa whoa..


Who makes this???? Oxford, london medical speciality unis...sorry to bore you about the tvs, but I've been to oxford but never in the college.. but I know..these places have a large number of young foreign students of the Chinese variety in London.. kids of older more trained people.


And the Russians and Chinese buying up all the london property.

I reckon we are ****ed tbh.

Adrian Hill who is one of the scientists involved is well renowned, I would be happy enough with this vaccine

Care homes and Health staff will be first and they need two doses a month apart, we are looking at March by the time all the over 65s who want it get it